Successful prevention of tunneled, central catheter infection by antibiotic lock therapy using cefotaxime

Journal of Research in Medical Sciences

Volumn 16, Issue 3, 2011, Pages 303-309

  Mortazavi, Mojgan ^a   Alsaeidi, Samira ^a   Sobhani, Roohollah ^b   Salimic, Fereshte ^c   Atapour, Abdolamir ^a   Sharif, Nima ^d   Akbari, Mojtaba ^a   Pakzad, Bahram ^a   Jazi, Amir Hosein Davarpanah ^e  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GONABAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d ROSS UNIVERSITY SCHOOL OF MEDICINE   (Dominica)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catheter; Cefotaxime; Hemodialysis; Heparin; Lock solution infection

Indexed keywords

CEFOTAXIME; HEPARIN;

ADULT; ARTICLE; BLOOD SAMPLING; CATHETER; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; MALE; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TUNNELED CUFFED CATHETER;

EID: 79955488627     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. UK Renal Registry. New Adult Patients Starting Renal Replacement Therapy in the UK in 2004. Bristol: UK Renal Registry; 2005. p. 12-26.
2. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, et al. The spectrum of infection-related morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant 2005; 20(6): 1180-6.
3. U.S. Renal Data System, USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
4. Saxena AK, Panhotra BR. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. J Nephrol 2005; 18(6): 755-63.
5. Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int 2002; 62(2): 620-6.
6. Al Hwiesh AK. Tunneled catheter-antibiotic lock therapy for prevention of dialysis catheter-related infections: a single center experience. Saudi J Kidney Dis Transpl 2008; 19(4): 593-602.
7. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19(6): 1546-51.
8. Develter W, De Cubber A, Van Biesen W, Vanholder R, Lameire N. Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs 2005; 29(5): 399-405.
9. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9(5): 869-76.
10. Dopirak M, Hill C, Oleksiw M, Dumigan D, Arvai J, English E, et al. Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 2002; 23(12): 721-4.
11. Battistella M, Bhola C, Lok CE. Long-term Follow-up of the Hemodialysis Infection Prevention With Polysporin Ointment (HIPPO) Study: A Quality Improvement Report. Am J Kidney Dis 2011; 57(3): 432-41.
12. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34(6): 1114-24.
13. Krishnasami Z, Carlton D, Bimbo L, Taylor ME, Balkovetz DF, Barker J, et al. Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61(3): 1136-42.
14. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19(5): 1237-44.
15. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36(12): 1539-44.
16. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17(10): 1802-7.
17. Chazan JA, London MR, Pono LM. Long-term survival of vascular accesses in a large chronic hemodialysis population. Nephron 1995; 69(3): 228-33.
18. Huraib S, Askar A, Abu-Aisha H, al Wakeel J. Prevalence of infection from subclavian dialysis catheters with two different postinsertion catheter cares: a randomized comparative study. Angiology 1994; 45(12): 1047-51.
19. Hoen B, Kessler M, Hestin D, Mayeux D. Risk factors for bacterial infections in chronic haemodialysis adult patients: a multicentre prospective survey. Nephrol Dial Transplant 1995; 10(3): 377-81.
20. Fong IW. Prevention of haemodialysis and peritoneal dialysis catheter related infection by topical povidoneiodine. Postgrad Med J 1993; 69 Suppl 3: S15-7.
21. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51(RR-10): 1-29.
22. Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am J Kidney Dis 2006; 48(4): 596-605.
23. Taal MW, Fluck RJ, McIntyre CW. Preventing catheter related infections in haemodialysis patients. Curr Opin Nephrol Hypertens 2006; 15(6): 599-602.
24. Dittmer ID, Sharp D, McNulty CA, Williams AJ, Banks RA. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51(1): 34-9.
25. Carratala J, Niubo J, Fernandez-Sevilla A, Juve E, Castellsague X, Berlanga J, et al. Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother 1999; 43(9): 2200-4.
26. Kim SH, Song KI, Chang JW, Kim SB, Sung SA, Jo SK, et al. Prevention of uncuffed hemodialysis catheterrelated bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int 2006; 69(1): 161-4.
27. Saxena AK, Panhotra BR, Sundaram DS, Al Hafiz A, Naguib M, Venkateshappa CK, et al. Tunneled catheters' outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int 2006; 70(9): 1629-35.
28. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton) 2006; 11(4): 299-305.
29. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 2008; 51(2): 233-41.
30. McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int 2004; 66(2): 801-5.
31. Chow KM, Poon YL, Lam MP, Poon KL, Szeto CC, Li PK. Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients. Hong Kong Med J 2010; 16(4): 269-74.
32. Dogra GK, Herson H, Hutchison B, Irish AB, Heath CH, Golledge C, et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J Am Soc Nephrol 2002; 13(8): 2133-9.
33. Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Org, Pease S, et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009; 301(12): 1231-41.
34. Allon M. Prophylaxis against dialysis catheter-related bacteremia: a glimmer of hope. Am J Kidney Dis 2008; 51(2): 165-8.
35. Alvarez-Lerma F, Palomar M, Olaechea P, Sierra R, Cerda E. [Cefotaxime, twenty years later. Observational study in critically ill patients]. Enferm Infecc Microbiol Clin 2001; 19(5): 211-8.